Campbell Neurosciences reports findings with Campbellcell in animal model of bipolar disorder

Sep. 20, 2022

Therapeutic Solutions International Inc. has announced promising data on the use of Campbellcell for treatment of bipolar disorder by the company's suicide prevention-based spin-off Campbell Neurosciences Inc.

BioWorld Science Stem cells Neurology/psychiatric

Today's news in brief

BioWorld

BioWorld briefs for Dec. 3, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for December 3, 2024.

Illustration of man holding magnifying glass to human body model showing muscle anatomy

In muscular dystrophies, gene therapies race the clock

BioWorld

Since the isolation of the gene that causes Duchenne muscular dystrophy (DMD), scientists have progressed in understanding the mechanisms that lead to muscular...

AI-generated illustration of heart and metabolic impact

Bridgebio, with FDA approval, faces Pfizer in ATTR

BioWorld

With the U.S. FDA approval of Attruby (acoramidis) for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), Bridgebio Pharma Inc. is taking on an industry...

Radiopharma Telix acquires FAP-targeting agents for bladder cancer

BioWorld

Radiopharmaceutical company Telix Pharmaceuticals Ltd. has inked a deal worth up to AU$264 million (US$171 million) to license and develop next-generation...